PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 166 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 3.71 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $6,707,000 | +1.0% | 372,793 | +34.1% | 0.06% | +48.7% |
| Q4 2019 | $6,640,000 | +16.8% | 278,043 | +31.2% | 0.04% | 0.0% |
| Q3 2019 | $5,683,000 | +57.0% | 211,889 | +58.9% | 0.04% | +69.6% |
| Q2 2019 | $3,619,000 | -31.3% | 133,381 | -50.6% | 0.02% | -39.5% |
| Q4 2018 | $5,270,000 | +78.3% | 270,000 | +198.5% | 0.04% | +216.7% |
| Q1 2018 | $2,955,000 | +933.2% | 90,449 | +1606.6% | 0.01% | +1100.0% |
| Q3 2017 | $286,000 | -99.0% | 5,300 | -99.0% | 0.00% | -99.2% |
| Q2 2017 | $30,095,000 | +20.8% | 535,800 | -15.7% | 0.12% | +6.9% |
| Q1 2017 | $24,911,000 | +172.0% | 635,645 | +63.8% | 0.12% | +96.6% |
| Q2 2016 | $9,157,000 | +68.5% | 388,026 | +45.6% | 0.06% | +84.4% |
| Q1 2016 | $5,436,000 | -78.8% | 266,487 | -46.6% | 0.03% | -82.0% |
| Q4 2015 | $25,681,000 | – | 499,138 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 232,952 | $5,498,000 | 5.39% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,673,727 | $86,700,000 | 3.41% |
| Redmile Group, LLC | 1,466,537 | $34,610,000 | 3.31% |
| SECTORAL ASSET MANAGEMENT INC | 1,229,382 | $29,013,000 | 3.00% |
| HARVEY CAPITAL MANAGEMENT INC | 206,530 | $4,874,000 | 2.44% |
| Marcus Capital, LLC | 75,150 | $1,774,000 | 1.87% |
| Cormorant Asset Management, LP | 396,000 | $9,346,000 | 1.32% |
| Rail-Splitter Capital Management, LLC | 221,414 | $5,225,000 | 1.25% |
| Temasek Holdings (Private) Ltd | 6,583,568 | $155,372,000 | 1.21% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 636,526 | $15,022,000 | 0.84% |